Clinical Trials Browser

Phase 1/2 × Terminated × lorvotuzumab mertansine × Clear all

NCT01237678 2018-01-18

A Study of IMGN901 for Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer

Phase 1/2 Terminated

181 enrolled 17 charts

Small Cell Lung Carcinoma